Phase 2b placebo-controlled trial of M72/AS01(E) candidate vaccine to prevent active tuberculosis in adults

Por Van Der Meeren, Olivier, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J., Diacon, Andreas, Blatner, Gretta L., Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C., Hellstrom, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine Jacqueline, Khatoon, Aisha, Bollaerts, Anne, Ginsberg, Ann M., Evans, Thomas G., Gillard, Paul, Tait, Dereck R.
Publicado no N Engl J Med (2018)

120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01(E) Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection

Por Meeren, Olivier Van Der, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J, Diacon, Andreas, Blatner, Gretta L, Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C, Hellstrom, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine J, Azam, Aisha K, Bollaerts, Anne, Ginsberg, Ann M, Evans, Thomas G, Gillard, Paul, Tait, Dereck R
Publicado no Open Forum Infect Dis (2018)